Non-invasive imaging test could predict which kidney cancer patients will benefit from anti-vascular therapy

A magnetic resonance imaging test that measures the volume of blood in tumours could help select which patients will benefit from drugs that block blood vessel growth, a new study shows.
Institute of Cancer Research